Nothing Special   »   [go: up one dir, main page]

DE3682368D1 - Mitogene peptide. - Google Patents

Mitogene peptide.

Info

Publication number
DE3682368D1
DE3682368D1 DE8686870149T DE3682368T DE3682368D1 DE 3682368 D1 DE3682368 D1 DE 3682368D1 DE 8686870149 T DE8686870149 T DE 8686870149T DE 3682368 T DE3682368 T DE 3682368T DE 3682368 D1 DE3682368 D1 DE 3682368D1
Authority
DE
Germany
Prior art keywords
asn
tyr
leu
pro
mitogenic peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686870149T
Other languages
English (en)
Inventor
George Dubar Wilner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Application granted granted Critical
Publication of DE3682368D1 publication Critical patent/DE3682368D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8686870149T 1985-10-15 1986-10-14 Mitogene peptide. Expired - Lifetime DE3682368D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/787,411 US4704451A (en) 1985-10-15 1985-10-15 Mitogenic peptides

Publications (1)

Publication Number Publication Date
DE3682368D1 true DE3682368D1 (de) 1991-12-12

Family

ID=25141385

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686870149T Expired - Lifetime DE3682368D1 (de) 1985-10-15 1986-10-14 Mitogene peptide.

Country Status (13)

Country Link
US (1) US4704451A (de)
EP (1) EP0220157B1 (de)
JP (1) JPH0689031B2 (de)
AT (1) ATE69240T1 (de)
AU (1) AU595249B2 (de)
CA (1) CA1299814C (de)
DE (1) DE3682368D1 (de)
DK (1) DK169346B1 (de)
FI (1) FI85379C (de)
IE (1) IE59403B1 (de)
IL (1) IL80300A (de)
NO (1) NO169127C (de)
ZA (1) ZA867783B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2131389A1 (en) * 1992-03-02 1993-09-16 John M. Maraganore Thrombin receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376071A (en) * 1980-08-21 1983-03-08 Research Corporation Mitogenic spinal cord growth factor
US4517338A (en) * 1983-06-20 1985-05-14 Chiron Corporation Multiple reactor system and method for polynucleotide synthesis
US4515920A (en) * 1984-04-30 1985-05-07 The Rockefeller University Synthesis of peptides and proteins

Also Published As

Publication number Publication date
NO864088L (no) 1987-04-21
FI864146A0 (fi) 1986-10-14
NO169127B (no) 1992-02-03
IL80300A0 (en) 1987-01-30
IL80300A (en) 1991-07-18
FI85379C (fi) 1992-04-10
ZA867783B (en) 1987-08-26
US4704451A (en) 1987-11-03
EP0220157B1 (de) 1991-11-06
FI85379B (fi) 1991-12-31
IE59403B1 (en) 1994-02-23
JPS62174098A (ja) 1987-07-30
NO864088D0 (no) 1986-10-14
FI864146A (fi) 1987-04-16
JPH0689031B2 (ja) 1994-11-09
NO169127C (no) 1992-05-13
DK489086D0 (da) 1986-10-14
DK169346B1 (da) 1994-10-10
EP0220157A3 (en) 1989-02-15
DK489086A (da) 1987-04-16
ATE69240T1 (de) 1991-11-15
AU595249B2 (en) 1990-03-29
CA1299814C (en) 1992-04-28
IE862705L (en) 1987-04-15
AU6387886A (en) 1987-04-16
EP0220157A2 (de) 1987-04-29

Similar Documents

Publication Publication Date Title
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
ES8607732A1 (es) Procedimiento para producir un preparado implantable de un peptido regulador, uno de sus analogos o una de sus sales fisiologicamente compatibles.
DK151985A (da) Humant fysiologisk aktivt polypeptid
FI94254B (fi) Menetelmä terapeuttisesti aktiivisten peptidijohdannaisten valmistamiseksi
ES8606390A1 (es) Un procedimiento para preparar nuevos peptidos atriales.
ATE81135T1 (de) Aktive thymopentin-analoga.
EP0182372A3 (de) Faktor-VIII-gerinnende Polypeptide
HUT66309A (en) Bpc peptides, their preparation and therapeutic use
IT8421622A0 (it) Procedimento per la preparazione di peptidi.
EP0225020A3 (de) Peptide, welche in der Sequenz Einheiten von Aminosäureresten 17 bis 24 von VIP enthalten
HUT42102A (en) Process for preparing peptides with pharmaceutical activity
GB2177091B (en) 5,6-epoxy-7-oxabicycloheptane substituted amino prostaglandin analogs useful in the treatment of thrombotic disease
DE3682368D1 (de) Mitogene peptide.
DK513283D0 (da) Biologisk aktive peptider,isaer til brug i dyrefodere
AU2817589A (en) Amino anthracenediones-bis platinum complexes, useful as antitumoral agents
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
EP0445304A4 (en) Isolated, physiologically active human thrombomodulin polypeptide
DE3869939D1 (de) Biologisch wirksame peptide.
EP0175323A3 (en) Biologically active peptides, processes for preparing them and pharmaceutical compositions
GB8606293D0 (en) Antigenically active protein
GB2180746B (en) Compositions for administering biologically active peptides via mucous membranes
ES8606248A1 (es) Un procedimiento para la produccion de una dihidroxifenil- glicina opticamente activa
NO864689D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive peptider.
GB8506970D0 (en) Antigenically active protein

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee